GlassScriptPhysician profile
Chintu Sharma
NPI 1710032099
$1,555.38
in general payments reported to CMS, 2019-2025
16 companies · $405 in 2025
The $405 reported for 2025 was more than what 88% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.97 · 2023: $631 · 2024: $500 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,536.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $385.38 | 2023-2024 | Xarelto |
| Abbvie INC. | $244.54 | 2022-2025 | Avycaz |
| Novo Nordisk INC | $202.50 | 2024-2025 | Wegovy, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $188.41 | 2023-2025 | Lifevest |
| Mylan Specialty L.P. | $130.86 | 2023 | Yupelri, Yupelri |
| Viatris Specialty LLC | $120.00 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $67.53 | 2023-2024 | Dificid, Verquvo |
| Abiomed | $38.98 | 2025 | |
| Heartflow, INC. | $33.24 | 2025 | |
| Novartis Pharmaceuticals Corporation | $30.78 | 2023 | |
| United Therapeutics Corporation | $30.45 | 2023 | Tyvaso |
| Cumberland Pharmaceuticals, INC. | $18.68 | 2025 | Vibativ |
| Paratek Pharmaceuticals, INC. | $18.00 | 2023 | Nuzyra |
| Gilead Sciences, INC. | $16.14 | 2024 | Veklury |
| E.R. Squibb & Sons, L.L.C. | $14.95 | 2023 | Camzyos |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chintu Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.